To investigate the role of cell viability and metabolism on the myocardial kinetics of a new tracer, technetium-99m-methoxyisobutyl isonitrile (Tc-99m-MIBI), 250 ,uCi/l Tc-99m-MIBI was infused in isolated rat hearts under constant flow conditions. The hearts were studied after inducing irreversible damage by cytochrome c oxidase inhibitor sodium cyanide (n=8) or sarcolemmal membrane detergent Triton X-100 (n=8). The 
To investigate the role of cell viability and metabolism on the myocardial kinetics of a new tracer, technetium-99m-methoxyisobutyl isonitrile (Tc-99m-MIBI), 250 ,uCi/l Tc-99m-MIBI was infused in isolated rat hearts under constant flow conditions. The hearts were studied after inducing irreversible damage by cytochrome c oxidase inhibitor sodium cyanide (n=8) or sarcolemmal membrane detergent Triton X-100 (n=8). The control hearts (n=6) received no toxins. Mean Tc-99m-MIBI peak accumulation activity was significantly reduced after cyanide (51.1±44.2% of control, p<0.01) and Triton (13.8±2.7% of control, p<0.001) administration. Kinetic studies also showed marked reduction in accumulation rates and marked increase in clearance rates for cyanide (p<0.01) and Triton (p<0.01) groups compared with controls. Potential changes in regional flow distribution were assessed using microspheres. When peak accumulation activity was corrected for these changes, there remained significant differences between the groups. In the cyanide and Triton groups, irreversible cell injury was confirmed by creatine kinase and lactate dehydrogenase release, triphenyl tetrazolium chloride staining, and electron microscopy. All the cells were viable in the control group. We conclude that the accumulation and clearance kinetics of Tc-99m-MIBI are significantly affected by cell viability. Tc-99m-MIBI kinetics appear to be dependent on sarcolemmal integrity and to a lesser extent on aerobic metabolism. (Circulation 1990; 82:1802 -1814 T echnetium-99m-methoxyisobutyl isonitrile (Tc99m-MIBI) is a new synthetic lipophilic, cationic, myocardial perfusion tracer, and it represents a new class of cardiac perfusion agents. It has a first-pass myocardial extraction fraction of 65%W (38- 57% average peak extraction fraction2'3) and is avidly retained by the myocytes.'-'1 Its clinical efficacy as a perfusion tracer is similar to that of thallium-201. [12] [13] [14] [15] [16] [17] [18] [19] [20] Compared with thallium-201, Tc-99m-MIBI has the advantages of higher emission energy with less attenuation, shorter half-life with a higher permitted dose leading to greater resolution, and a longer residence time functionally resembling microspheres.1,4-6,12,13,21
Tc-99m-MIBI accumulates linearly in the myocardium according to blood flow in much the same manner as microspheres.',4-10 It exhibits slow myocardial clearance and shows little redistribution with time.'-1" Tc-99m-MIBI has the potential for assessing the efficacy of interventions such as thrombolysis and reperfusion and the diagnosis and prognosis of various coronary syndromes.21-39 However, whether MIBI kinetics are affected by myocardial viability is still unresolved.7 21 34-5' This issue has important implications in understanding kinetic mechanisms of cations in the myocyte and in determining the clinical usefulness of these agents. Results from previous experiments have been difficult to interpret because of the inability to dissociate the contribution of flow from that of viability in the ischemic and infarcted regions of various models.
Therefore, we performed a series of experiments designed to determine the role of irreversible cell injury on Tc-99m-MIBI kinetics in an isolated rat heart model independent of significant flow limitations. Irreversible cellular injury was induced by either an inhibitor of aerobic metabolism, sodium cyanide,52-57 or a membrane detergent, Triton X-100.58-63
Methods The study was designed to compare the kinetics of Tc-99m-MIBI tracer accumulation and clearance in a constant-flow Langendorfl preparation under conditions of control with standard Krebs-Henseleit buffer infusion, sodium cyanide infusion, or Triton X-100 infusion.
Experimental Preparation
All hearts were perfused with Krebs-Henseleit buffer prepared in the standard manner (mmol/l): 1.2 KH2PO4, 1.2 MgS04, 1.75 CaCl2, 4.7 KCI, 0.5 EDTA, 118.0 NaCl, 25.0 NaHCO3, and 11.0 dextrose. This was continuously bubbled with 95% 02-5% CO2 at a rate of 3 1/min to maintain pH at 7.4+±0.05 and PO2 at 500±50 mm Hg. The cyanide perfusate was prepared by dissolving 980.2 mg sodium cyanide in 2 1 KrebsHenseleit buffer to make a 10.0 mmol/1 solution. Triton X-100 perfusate was prepared by adding 10 ml 100% Triton X-100 to 2 1 Krebs-Henseleit buffer to make 0.5% solution of Triton X-100.
To study tracer accumulation kinetics, radioactive buffer was prepared by adding 500 ,Ci Tc-99m-MIBI to 21 of the above described Krebs-Henseleit buffer to make a solution containing 250 ,uCi/l Tc-99m-MIBI.
Isolated, Perfused Heart Preparation
Male Sprague-Dawley rats (weighing 320-370 g, 3-4 months old) were anesthetized with 0.65 mg i.p. sodium pentabarbitol. Simultaneously, 500 units heparin was administered. After deep anesthesia was achieved, the heart was removed through a rapid right parasternal thoracotomy. The heart was then immediately placed in Krebs-Henseleit buffer at 40 C. The aorta was identified, cleared, and connected to the perfusion apparatus. Throughout the experiment, the buffer was infused at a constant flow of 14 m/min, which was controlled by a digital roller pump (Masterflex, Parmer Instruments, Burlington, I1L). Constant temperature was maintained at 370 C by a coil-condenser heat-exchanger circulator connected to an MGW Lauda 20 waterbath. A warm saline-filled intraventricular latex balloon, inserted through the left atrial appendage, was used to continuously measure left ventricular developed pressure. The left ventricular developed pressure and aortic perfusion pressure were continuously recorded on a physiological recorder (model 2800S, Gould Recorder, Cleveland, Ohio).
Tracer Kinetic Monitoring
The myocardial Tc-99m-MIBI activity was monitored during accumulation and clearance phases, at 10-second intervals with a collimated sodium iodide probe, placed 1 cm from the surface of the left ventricle. The output was interfaced with a discriminator, centered on the 140-keV peak, and the output was transferred to a multichannel analyzer (series 35 , Canberra-Packard, Meriden, Conn.) where data were displayed. Data were then transferred to an IBM personal computer for storage and quantitative analysis.
Experimental Protocol
All hearts were initially perfused with KrebsHenseleit buffer for 15 minutes to achieve stabilization. Thereafter, the hearts were divided into three groups.
Group 1 (control, n=6). Hearts were perfused for 30 minutes with radioactive Krebs-Henseleit buffer containing 250 ,uCi/l Tc-99m-MIBI to study the accumulation phase; then perfused with nonradioactive buffer (Krebs-Henseleit buffer without Tc-99m-MIBI) for 45 minutes to study the clearance phase. All flows were maintained at 14 ml/min. Bufferperfused rat heart experiments generally use flows of 10-14 ml/min.78.64 We chose the upper end of this range to avoid potentially significant reductions in regional flow causing ischemia. However, this flow rate is still much less than the maximum coronary flow rate for the normal rat, which is in excess of 20 ml/min/g. 65 Group 2 (cyanide, n=8). Hearts were first perfused with Krebs-Henseleit buffer with 10 mmol/l sodium cyanide for 30 minutes to achieve metabolic blockade. This perfusion was followed by the radioactive buffer perfusion for 30 minutes to study the accumulation phase, then the nonradioactive buffer infusion for 45 minutes to study the clearance phase. A subgroup of five hearts received an additional 5 mmol/1 sodium cyanide for 30 minutes during the radioactive buffer infusion (accumulation phase) to determine the effect of prolonged exposure to cyanide infusion on tracer kinetics and the degree of myocardial injury. All hearts were perfused throughout the experiment at 14 ml/min regardless of their contractile response to sodium cyanide.
Group 3 (Titon, n=8). Hearts were perfused with Triton X-100 0.5% solution for 5 minutes. This was followed by the radioactive buffer infusion for 30 minutes to study the accumulation phase, then the nonradioactive buffer infusion for 45 minutes to study the clearance phase. As with the other experimental groups, the hearts were perfused at 14 The heart was sliced horizontally, parallel to the long axis, through the apex and placed in 50 ml TTC, which contained 12.5 mg/ml tetrazolium, for 10 minutes. The positive staining pattern as a portion of the total myocardial cut surface was visually estimated. The heart staining was then categorized as normal, where all the myocardium was stained; absent, where no staining was visible; or partial, where only a portion of the myocardium was stained (all those in this category had between 25% and 75% of the total myocardium stained).
The other half of the heart was placed in universal fixative (4:1 gluteraldehyde: formalin), dehydrated in graded ethanol, and embedded in Epon/araldite epoxy resin according to standard techniques. Ultrathin sections were stained with saturated aqueous uranyl acetate and Reynold's lead citrate and examined using a Phillips EM 400 electron microscope.73,74 The interpretation of the electronmicrographs was performed by a cardiac pathologist unaware of the experimental status of the heart. In all, three of six hearts from the control group, four of eight from the cyanide group, and four of eight from the Triton group were examined by electron microscopy.
Assessment of Regional Myocardial Blood Flow by Microspheres
Although global flow was held constant in this model, significant alterations in regional myocardial blood flow to the endocardium could not be ruled out. Such alterations, if marked, can alter tracer delivery and correction would be necessary. Thus, a separate set of experiments was performed to assess regional blood flow.
With the same experimental preparation and model described above, 12 isolated rat hearts were divided into three groups: control (n=4), cyanide (n=4), and Triton (n=4). After the stabilization phase, each group received the respective toxins in the same dose as described above. At the end of the toxin infusion, or after the stabilization phase in the controls, 1.2 ,uCi tin-113-labeled microspheres (DuPont, Billerica, Mass.; 15.5+0.1-,um in diameter; half-life, 115.1 days; principal photons, 393 keV, 2.43 x 104 spheres/,Ci) were injected into the system during 20 seconds. The microsphere suspension was agitated for 20 minutes and was added to the system at 7.0 cm from the heart. Activity of several equal volume samples was well counted to ensure uniformity of dose, and the syringe activity was measured again after injection to confirm negligible residual activity.
The quantity of microspheres was chosen to ensure that at least 200 microspheres75,76 would be present in the smallest expected sample with normal blood flow, although evidence suggests that fewer microspheres are actually needed.77,78 The dose of microspheres was also chosen to ensure that the number of spheres per milligram would be far less than the maximum arteriolar density of 161.5 spheres/mg in the rat heart.79
Two minutes after the microsphere injection, the hearts were removed from the apparatus. The right ventricle and atria of each heart were excised and discarded. The left ventricle was then transected into two rings. Each left ventricle ring was divided into four sections, and each section was divided into two segments (epicardial and endocardial). Each segment was weighed, and its activity was counted in a gamma counter (Autogamma 5650, United Technologies, Packard, Mississauga, Ontario).
Ethics
The study protocol was approved by the Committee on Animal Research at the Toronto General Hospital and was performed in accordance with the "Position of the American Heart Association on Research Animal Use," adopted on November 11, 1984 , by the American Heart Association.
Statistical Analysis
The high-resolution time-activity data collected by the multichannel analyzer were first subtracted for background and corrected for physical decay. Each accumulation phase curve and each clearance phase curve was then individually fitted to an exponential function to allow characterization of the rate constant. Numerical constants (K for accumulation, K' for clearance) were established for each individual curve.
For the assessment of regional blood flow, an endocardial to epicardial ratio of total counts per milligram was established for each heart. Also, the mean of the endocardial fraction of the total flow was used as a correction factor for regional flow differences to the endocardium. Total Tc-99m-MIBI uptake was divided by this correction factor to calculate the corrected Tc-99m-MIBI uptake.
The mean accumulation (K) and clearance (K') constants, the means of total Tc-99m-MIBI uptake, CK and LDH release, endocardial to epicardial microsphere distribution ratio, and corrected Tc-99m-MIBI uptake were compared among the three experimental groups by analysis of variance, with intentional post-hoc subgroup testing between pairs of groups by the Newman-Keuls technique.
Results

Hemodynamic Recordings
Examples of hemodynamic recordings are shown in Figure 1 . Continuous intraventricular pressure recordings showed that the mean systolic pressures at end of the stabilization period were 58.0+12. 4 what we have observed previously in isolated heart models in which Tc-99m-MIBI kinetics were studied.8,933 For the cyanideinjured hearts, the peak accumulation was lower, and initial clearance was more rapid. This reduced peak accumulation and rapid clearance were even more striking after Triton-induced injury.
Peak accumulation activity represented as a percentage of control activity is shown in Figure 3A . Cyanide-injured hearts had a reduced peak activity at 51.1±44.2% that of control (p<0.01), and Tritoninjured hearts showed a reduced peak activity to 13.8±2.7% of control (p<0.001 versus control, p<0.05 versus cyanide).
Curves reconstructed from the mean K constants of accumulation for each experimental group are shown in Figure 4 . The constants are listed in the figures and are significantly different between each group. Cyanide-injured hearts had reduced accumulation compared with the control hearts. Triton caused even greater reduction in accumulation.
By assigning the individual peak accumulation a value of 1.0 for each group and by applying the mean K' constants for clearance, proportional clearance curves were constructed (Figure 4) . Clearance was distinctly more rapid in the cyanide and Triton groups than in the control group (p<0.05 for each versus control). Figure 5 shows the extent of irreversible myocardial cell injury based on total CK release for the first 90 minutes in each group. Cyanide caused almost a sevenfold increase in CK release compared with control (control mean CK, 44.6± 7.9 IU; cyanide mean CK, 298.4+ 109.5 IU;p<0.01). Triton disruption ( Figure 6 ). Triton-injured cells showed much more extensive myocyte changes. Nearly all the mitochondria were enlarged and irregularly shaped, with marked loss of cristae. Concentric lamellar structures composed of electron-dense material were also seen; they had double membranes and were likely mitochondria as well. Z bands were irregular, sarcoplasmic reticulum and T-tubules were dilated, and there was marked intracellular edema. Nuclei showed chromatin clumping. However, the most significant change was the marked sarcolemmal disruption ( Figure 7) . The cell membrane, mitochondria, and nuclear changes seen are those described by others72,80,81 to represent irreversible cell injury.
Assessment of Cellular Injury
Assessment of Regional Microsphere Distribution
The total blood flow during the experiment was held constant at 14 ml/min. However, the endocardial: epicardial ratios for microsphere uptake were as follows: controls, 1.19+0.14; cyanide group, 0.74+0.04 (p<0.05); and Triton group, 0.60±0.13 (p<O.O5). The normal endocardial to epicardial microsphere distribution ratio for the rat heart in the intact animal has been shown to be 0.88±0.09.65 Thus, the endocardium showed a net reduction in flow with injury, and as a fraction, it represented 54% of the total flow in the control group, 42% of total flow in the cyanide group, and 38% in the Triton group.
After the microsphere redistribution was corrected for the endocardial fraction of the total flow, the peak accumulations of Tc-99m-MIBI, as a percentage of control, were 66 +34% for the cyanide group (p <0.05) and 20+2% for the Triton group (p<0.01). There remains a significant reduction in Tc-99m-MIBI accumulation after cyanide and Triton ( Figure 3B ).
Discussion
The importance of flow in determining myocardial uptake and distribution of Tc-99m-MIBI as a perfuCm There is evidence that low-flow ischemia without infarction does not alter the relation of Tc-99m-MIBI uptake and blood flow.32 '36 In dog models of short occlusions with reperfusion and stunning, Tc-99m-MIBI uptake is either normal36 or increased. 8, 34 In the presence of myocardial infarction, various conclusions have been reported on Tc-99m-MIBI kinetics.21 '35'40-42 In one such study by Freeman et al,40 thallium-201 uptake was found to be directly related to myocardial viability, but Tc-99m-MIBI uptake was also markedly reduced in the infarct zone. In a separate study, Freeman et a141 concluded that cell viability was necessary for Tc-99m-MIBI uptake. Sinusas et a135 reported that Tc-99m-MIBI activity was 25% of normal in a reperfused infarct region where flow was restored to 86% of normal, and they concluded that Tc-99m-MIBI reflects ischemic conditions and not just flow restoration. Furthermore, Verani et a121 noted that during occlusion Tc-99m-MIBI counts correlated well with flow rates, but during reperfusion, this correlation was poor, implying that uptake may also reflect cell metabolic integrity. In contrast, in a similar study with a longer occlusion time, Soufer et a142 reported Tc-99m-MIBI uptake was actually increased in the infarct zone relative to flow. Many of these models suffer from the problem of inability to clearly separate stunned from infarcted myocardium and the effect of variable flow during reperfusion.
The relation between Tc-99m-MIBI clearance and viability is also confusing. In a 2-hour occlusion model with reperfusion, Canby et a143 showed that Tc-99m-MIBI washout may be increased in the reperfused tissue similar to thallium-201. Although they attributed this to reduced extraction with increased flow, it can also relate to metabolic and viability changes in the risk zone. In an isolated rat heart preparation, Okada and Glover7 demonstrated that myocardial MIBI washout rate was significantly increased by ischemic flow rates, thus implying a metabolic-dependent component to MIBI retention. However, in an occlusion-reperfusion dog model, these same investigators44 reported that Tc-99m-MIBI's clearance was not altered by reperfusion or infarction. Here, they concluded clearance is not dependent on the metabolic state. However, the infarction group without reperfusion could have had reduced uptake on the basis of reduced flow. When examining a heavily flow-dependent tracer, clearance rate will vary with blood flow and tissue concentration. Therefore, these data cannot rule out the possibility that MIBI clearance is viability and metabolism dependent.
Although some of these studies do support the hypothesis that Tc-99m-MIBI kinetics depend on cell viability, conflicting data clearly exist. All of these studies had variable states of flow (ischemia, reperfusion, hyperemia, and no-reflow), all of which will influence Tc-99m-MIBI kinetics. In addition, there is a large admixture of metabolic states in the reperfused myocardium including normal, ischemic, stunned, and infarcted areas. The actual separation of the contribution of flow versus that of metabolism and viability on MIBI kinetics is thus difficult.
To address these deficiencies and conflicting information, we sought to study the effect of viability on Tc-99m-MIBI kinetics by using a model where global flow is held constant and where cell viability is altered in a controlled fashion, independent of flow. Although there were some variations in regional flow distribution, this did not alter our conclusions. Although global flow was held constant, we investigated the regional microsphere distribution and found there was a difference in endocardial to epicardial flow ratios between the groups. The control group ratio was slightly greater than that expected for normal rats of 0.89±0.09,65 and the cyanide group ratio was slightly less. When the peak accumulation of Tc-99m-MIBI was corrected for the different endocardial fractions of total flow, there was still a significant difference in accumulation between the irreversibly injured groups and controls. Thus, the effect of viability on Tc-99m-MIBI kinetics far exceeded the small differences in regional flow, further strengthening our conclusions.
Tc-99m-MIBI Kinetics in a Nonflow-Limited Model of Injury
Cyanide and Triton induced irreversible injury and altered MIBI kinetics. Tc-99m-MIBI accumulation is reduced in the irreversibly injured cell. In addition to the greater amount of injury, Triton was associated with a more dramatic reduction in accumulation than cyanide. These results support the direct relation between membrane integrity and Tc-99m-MIBI uptake and accumulation. The effect of altered cell energy metabolism on the uptake and accumulation is likely shown indirectly through effects on the membrane.
Clearance of MIBI was also markedly altered by irreversible injury. The usual avid retention of MIBI is no longer observed after irreversible injury, and Tc-99m-MIBI is rapidly cleared from the cell. This rapid clearance was seen with both Triton and cyanide but was not significantly different between these two groups. There are two possible explanations for this phenomenon. Based on the results of our study and other available data in the literature, we propose the following model of Tc-99m-MIBI kinetics (Figure 8 ). In the presence of normal flow in viable myocardium, the uptake process occurs primarily by diffusion, driven by both electrical and concentration gradients. MIBI then binds to a cellular site in a process that is sensitive to the alterations in cellular aerobic metabolism. As long as the electrical and concentration gradients are maintained, this binding will take place. The The inability to separate flow and viability by other models721,35-4244 makes these results in a nonflowlimited model clinically relevant. The clinical implication is that an imaging defect on an MIBI scan may represent reduced flow or loss of cell viability with or without reduced flow. The corollary of this is that a normal MIBI scan represents normal flow and the presence of cell viability. If two scans were compared in which flow conditions were different in a viable region, a flow-enhancing effect would be noted. If the area was necrotic, then there would be an identical defect despite changes in flow conditions. In the assessment of reperfusion, MIBI is known to be able to distinguish failed from successful therapy.21-28 Our study further suggests that MIBI may also be able to detect myocardial viability.
